Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by A. Basha
OUTCOMES IN DONATION AFTER CIRCULATORY DEATH CARDIAC TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
BACKGROUND Donation After Circulatory Death (DCD) donors represent a valued source of donor organs in the current setting of organ shortage. Historically, DCD donors were less preferred than Donation After Brain Death (DBD) donors for cardiac transplantation due to a warm ischemic period in the procurement process.
ANTIPLATELET THERAPY PRESCRIPTION PRACTICES FOR ACUTE CORONARY SYNDROME: A DECADE ANALYZED
Guidelines recommend dual antiplatelet therapy (DAPT) with acetylsalicylic acid (ASA) and ticagrelor following acute coronary syndrome (ACS) regardless of management strategy. Despite this, prescription practices lag and appropriate DAPT is not utilized. We aimed to trend differences in P2Y12 inhibitor prescriptions between ACS patients managed medically, with percutaneous intervention (PCI) or coronary artery bypass grafting (CABG).
STORY OF A SMALL SCAR: ANALYSING THE EVIDENCE FOR MINIMALLY INVASIVE MITRAL VALVE SURGERY
Minimally invasive mitral valve surgery (MMVS) is increasingly used. While proponents argue reduced transfusion rates and shorter hospital stays, whether this approach leads to better long-term outcomes remains unclear. We conducted a systematic review and meta-analysis comparing MMVS to conventional sternotomy for mitral valve surgery.
ANTI-PLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFTING: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Aspirin (ASA) monotherapy is the standard of care after coronary artery bypass grafting (CABG), but the benefits of more intense antiplatelet therapy, specifically dual antiplatelet therapy (DAPT), has not been well-established in all CABG patients.
IMPACT OF COMPLETENESS OF REVASCULARIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PRESENTATION
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. FiguresIn ST-elevation myocardial infarction (STEMI), 40-60% of patients present with multivessel disease (MVD). In MVD, aside from the culprit vessel, there is an atherosclerotic lesion present in at least one non-infarct related artery (nIRA).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with A.
Contact A., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack